203 related articles for article (PubMed ID: 14967766)
1. The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
Tartaglia MC; Narayanan S; Francis SJ; Santos AC; De Stefano N; Lapierre Y; Arnold DL
Arch Neurol; 2004 Feb; 61(2):201-7. PubMed ID: 14967766
[TBL] [Abstract][Full Text] [Related]
2. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM
J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
[TBL] [Abstract][Full Text] [Related]
3. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
[TBL] [Abstract][Full Text] [Related]
4. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
[TBL] [Abstract][Full Text] [Related]
5. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
Arnold DL; Riess GT; Matthews PM; Francis GS; Collins DL; Wolfson C; Antel JP
Ann Neurol; 1994 Jul; 36(1):76-82. PubMed ID: 8024266
[TBL] [Abstract][Full Text] [Related]
6. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.
Narayanan S; Fu L; Pioro E; De Stefano N; Collins DL; Francis GS; Antel JP; Matthews PM; Arnold DL
Ann Neurol; 1997 Mar; 41(3):385-91. PubMed ID: 9066360
[TBL] [Abstract][Full Text] [Related]
7. [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis].
Pascual-Lozano AM; Martínez-Bisbal MC; Boscá-Blasco I; Valero-Merino C; Coret-Ferrer F; Martí-Bonmatí L; Martínez-Granados B; Celda B; Casanova-Estruch B
Rev Neurol; 2007 Oct 16-31; 45(8):468-73. PubMed ID: 17948212
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B
Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072
[TBL] [Abstract][Full Text] [Related]
9. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
11. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis.
Mostert JP; Sijens PE; Oudkerk M; De Keyser J
Neurosci Lett; 2006 Jul; 402(1-2):22-4. PubMed ID: 16644118
[TBL] [Abstract][Full Text] [Related]
13. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
Bjartmar C; Kidd G; Mörk S; Rudick R; Trapp BD
Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
[TBL] [Abstract][Full Text] [Related]
14. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
Oh J; Pelletier D; Nelson SJ
Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
[TBL] [Abstract][Full Text] [Related]
15. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients.
Fu L; Wolfson C; Worsley KJ; De Stefano N; Collins DL; Narayanan S; Arnold DL
NMR Biomed; 1996 Dec; 9(8):339-46. PubMed ID: 9176888
[TBL] [Abstract][Full Text] [Related]
16. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.
De Stefano N; Bartolozzi ML; Guidi L; Stromillo ML; Federico A
J Neurol Sci; 2005 Jun; 233(1-2):203-8. PubMed ID: 15949506
[TBL] [Abstract][Full Text] [Related]
18. Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.
Khan O; Shen Y; Bao F; Caon C; Tselis A; Latif Z; Zak I
J Neuroimaging; 2008 Jul; 18(3):314-9. PubMed ID: 18304034
[TBL] [Abstract][Full Text] [Related]
19. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis.
Inglese M; Ge Y; Filippi M; Falini A; Grossman RI; Gonen O
Neuroimage; 2004 Apr; 21(4):1825-9. PubMed ID: 15050603
[TBL] [Abstract][Full Text] [Related]
20. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings.
Kim EA; Cheong HK; Choi DS; Sakong J; Ryoo JW; Park I; Kang DM
Neurotoxicology; 2007 Mar; 28(2):276-83. PubMed ID: 16824604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
